Filing Flows › Evolent Health (EVH) › Q1 2025
Evolent Health (EVH) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 9, 2025
Evolent Health (EVH) reported revenue of $484M for the first quarter 2025 (Q1 2025), -24% from a year earlier and -25% from the quarter before. Operating margin was -0.3%, net loss $64.6M (13.4% of revenue).
Evolent Health, Q1 2025: revenue $484M (-24% year over year), operating margin -0.3%, net loss $64.6M, operating cash flow $4.6M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $484M | -25% | -24% |
| Operating profit | −$1.6M | — | — |
| Net earnings | −$64.6M | — | — |
| Operating cash flow | $4.6M | — | -7% |
What changed
Revenue was $483.6M in Q1 2025, down 24% year over year and down 25% from the previous quarter.
Operating costs exceeded revenue by $1.6M, an operating margin of -0.3%. Total costs fell 26% while revenue fell 24%. The quarter ended with a net loss of $64.6M, wider than the previous quarter's $22.8M loss. Net interest and other expense of $61.5M was the main reason.
Operating cash flow was $4.6M (down 7% year over year). Non-cash charges added back $24.1M of depreciation and amortization and $11.1M of share-based compensation. Working capital and other items added $34.0M.
Questions
What was Evolent Health's revenue in the first quarter 2025?
Evolent Health (EVH) reported revenue of $484M for the first quarter 2025 (Q1 2025), -24% from a year earlier and -25% from the quarter before.
Was Evolent Health profitable in the first quarter 2025?
Operating loss was $1.6M (-0.3% of revenue) and net loss $64.6M.
Source: Evolent Health 10-Q on SEC EDGAR.